Your Mammogram Report Now Tells You About Breast Density: The 2024 FDA Rule

A sentence added to millions of letters

The rule that changed mammogram reports was published in the Federal Register on March 10, 2023, amending 21 CFR Part 900 under the Mammography Quality Standards Act. It took effect on September 10, 2024.

Its most visible piece is the wording every facility must now send you. The final rule sets out two statements, and one of them has to appear in the summary you receive.

If your tissue is not dense: "Breast tissue can be either dense or not dense. Dense tissue makes it harder to find breast cancer on a mammogram and also raises the risk of developing breast cancer. Your breast tissue is not dense. Talk to your healthcare provider about breast density, risks for breast cancer, and your individual situation."

If your tissue is dense, the letter says the same thing up to that point, then: "Your breast tissue is dense. In some people with dense tissue, other imaging tests in addition to a mammogram may help find cancers."

The rule also swapped the old comparative terms "high density" and "low density" for the plainer "dense" and "not dense," to match how clinicians actually talk.

What density is measuring

Breasts contain fatty tissue and fibroglandular tissue, which is glandular and connective tissue. Density describes the proportion, as seen on a mammogram. It has nothing to do with how a breast feels, its size, or its firmness.

NCI describes four categories:

• almost entirely fatty tissue, found in about 10 percent of women.
• scattered fibroglandular tissue, mostly fatty with some dense areas, about 40 percent.
• heterogeneously dense tissue, many dense areas with some fat, about 40 percent.
• extremely dense tissue, almost all glandular and connective, about 10 percent.

The last two count as "dense." That means roughly half of women get the dense-tissue letter. Our page on breast density shows what the categories look like.

Why it matters twice

Density affects breast cancer risk in two separate ways, and the notification wording reflects both.

The first is masking. On a mammogram, dense tissue appears white. So do tumors. Finding a white spot against a white background is harder than finding it against dark fat. That is the reading problem.

The second is risk itself. NCI states that dense breasts are a risk factor for breast cancer, and that this risk is separate from the effect on reading the mammogram. NCI is equally clear that dense breasts are not an abnormal condition or a disease. They are common, they are normal, and they change the odds.

The question the rule does not answer

If dense tissue hides cancers, should people with dense breasts have extra scans?

NCI's answer is careful. There is not yet enough evidence to recommend for or against additional imaging such as ultrasound or MRI to screen for breast cancer in women with dense breasts, citing the U.S. Preventive Services Task Force. The notification says other tests "may help find cancers" in some people. It does not say they are recommended.

That gap is deliberate. Extra imaging finds more things, and not all of those things are cancer. More findings mean more biopsies, more anxiety, and more cost, without proof yet that lives are saved. Our page on mammograms covers the underlying test and its limits.

What to do with the letter

The useful response is a conversation, not a scan.

NCI suggests asking your provider:

• do I have dense breasts, based on my most recent mammogram?
• do you recommend additional screening for me?
• what are the benefits and drawbacks of those additional tests?
• what is my personal risk of breast cancer, given all my risk factors?

Density is one input among several. Age, family history, prior biopsies, genetic findings, and reproductive history all feed into a risk estimate, and that estimate is what should drive any decision about extra imaging.

When to get seen regardless

The rule concerns screening, which is for people without symptoms. A breast change is a different situation and does not wait for a schedule.

Book an appointment for a new lump or thickening in the breast or underarm, a change in the size or shape of one breast, skin that dimples or puckers, a nipple that turns inward, nipple discharge that is bloody or spontaneous, or redness or scaling on the nipple or breast skin. Say clearly that you have a new symptom rather than booking a routine screening visit, because the tests ordered are different. Our overview of breast cancer covers what happens next.

What this does and doesn't change

• The rule changes what you are told. It does not change what a mammogram can see.
• Dense tissue is not a diagnosis and not a disease. About half of women have it.
• Being told you have dense breasts does not mean you need an MRI. The evidence for extra imaging is unsettled.
• The notification does not replace a risk assessment. Density alone is not the whole picture.

Sources

• FDA: Updates Mammography Regulations to Require Reporting of Breast Density Information
• Federal Register: Mammography Quality Standards Act; Final Rule (March 10, 2023)
• NCI: Dense Breasts — Answers to Commonly Asked Questions
• SEER Cancer Stat Facts: Female Breast Cancer

How this page was made

An AI-assisted editorial system helped prepare this page. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown. Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.

Found an error, a broken source link, outdated information, or wording that feels insensitive? Report it here — we log and act on material corrections.